ICOTINIB for Non-small cell lung cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 15 adverse event reports in the FDA FAERS database where ICOTINIB was used for Non-small cell lung cancer.

Most Reported Side Effects for ICOTINIB

Side Effect	Reports	%	Deaths	Hosp.
Rash	14	34.2%	1	1
Hypertension	12	29.3%	0	0
Diarrhoea	10	24.4%	0	0
Malignant neoplasm progression	10	24.4%	2	2
Fatigue	9	22.0%	1	0
Bone marrow failure	7	17.1%	0	1
Proteinuria	7	17.1%	0	0
Vomiting	7	17.1%	2	0
Disease progression	6	14.6%	0	0
Haemorrhage	6	14.6%	0	0
Nausea	6	14.6%	2	0
Anaemia	5	12.2%	0	0
Leukopenia	5	12.2%	0	0
Liver injury	5	12.2%	0	1